Advanced in Short-Chain Acyl-CoA Dehydrogenase Deficiency

Romain Eschalier

CHU Clermont Ferrand
Clermont-ferrand, FR 
Clinical Trials:Currently Recruiting for 1 Trial
Advanced in Short-Chain Acyl-CoA Dehydrogenase Deficiency
CHU Clermont Ferrand
Clermont-ferrand, FR 
OverviewLocationsClinical Research

Overview

Romain Eschalier practices in Clermont-ferrand, France. Mr. Eschalier is rated as an Advanced expert by MediFind in the treatment of Short-Chain Acyl-CoA Dehydrogenase Deficiency. His top areas of expertise are Heart Block, Ventricular Fibrillation, Heart Failure, Transcatheter Aortic Valve Replacement (TAVR), and Cardiac Ablation.

His clinical research consists of co-authoring 130 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Short-Chain Acyl-CoA Dehydrogenase Deficiency.

Gender
Male

Locations

CHU Clermont Ferrand
Clermont-ferrand, France
Other Locations
CHU de Toulouse
Toulouse, 31000, France
Marseille, France
Nancy, France
Rennes, France
France
Bordeaux, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Clinical Trial of Atrial Fibrillation Patients Comparing Left Atrial Appendage Occlusion Therapy to Non-vitamin K Antagonist Oral Anticoagulants
Enrollment Status: Recruiting
Publish Date: February 27, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
WATCHMAN FLX Versus NOAC for Embolic ProtectION in in the Management of Patients With Non-Valvular Atrial Fibrillation
Enrollment Status: Active_not_recruiting
Publish Date: October 14, 2025
Intervention Type: Drug, Device
Study Phase: Not Applicable
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
Comparison of Anticoagulation With Left Atrial Appendage Closure After AF Ablation
Enrollment Status: Completed
Publish Date: September 18, 2025
Intervention Type: Device, Drug
Study Phase: Not Applicable
Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation
Comparison of Alcoholic Chlorhexidine 2% Versus Alcoholic Povidone Iodine for Infections Prevention With Cardiac Resynchronization Therapy Device Implantation
Enrollment Status: Completed
Publish Date: June 04, 2025
Intervention Type: Drug
Study Drugs: Alcoholic Povidone Iodine, Alcoholic Chlorhexidine
Study Phase: Phase 4
Personalized Therapy Study - Heart Failure Risk Status (TriageHF) Post Approval Study
Personalized Therapy Study - Heart Failure Risk Status (TriageHF) Post Approval Study
Enrollment Status: Active_not_recruiting
Publish Date: April 01, 2025
Intervention Type: Other
Impact Pronostique d'un événement Rythmique Ventriculaire Durant le Port de la LifeVest en Post-infarctus
Impact Pronostique d'un événement Rythmique Ventriculaire Durant le Port de la LifeVest en Post-infarctus
Enrollment Status: Completed
Publish Date: March 10, 2023
Intervention Type: Other
View 5 Less Clinical Trials

130 Total Publications

Countrywide introduction of pulsed field ablation for the treatment of atrial fibrillation: Acute results from the FRANCE-PFA registry.
Countrywide introduction of pulsed field ablation for the treatment of atrial fibrillation: Acute results from the FRANCE-PFA registry.
Journal: Heart rhythm O2
Published: July 30, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Eschalier's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 39 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile